Long-Term Safety and Efficacy of Spark-Sponsored Gene Therapies in Males With Hemophilia A

NCT03432520 · clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
29
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Spark Therapeutics, Inc.